Sofia D. Merajver, MD, PhD

Zitiert von

	Alle	Seit 2019
Zitate	24600	8333
h-index	85	45
i10-index	228	175

1700

850

425

1275

19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202464 169 275 265 262 266 285 283 468 557 589 637 623 836 870 985 908 1025 1087 1028 946 1062 1067 1224 1313 1247 1618 1510 1384 1240

Öffentlicher Zugriff

Alle anzeigen

128 Artikel

15 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Max WichaBestätigte E-Mail-Adresse bei umich.edu
Mousumi BanerjeeAnant M. Kshirsagar Collegiate Research Professor of Biostatistics, University of MichiganBestätigte E-Mail-Adresse bei umich.edu
Devin RosenthalSenior AssociateBestätigte E-Mail-Adresse bei nqcapital.com
Kent A GriffithCenter for Cancer Biostatistics, University of Michigan School of Public HealthBestätigte E-Mail-Adresse bei med.umich.edu
Michelle L WynnGoogle XBestätigte E-Mail-Adresse bei umich.edu
Dr. Subhojit DeyExecutive Director, Disha Foundation; Co-Founder & President, Prosinno Pvt. Ltd.Bestätigte E-Mail-Adresse bei dishafoundation.ngo
Richard GonzalezUniversity of MichiganBestätigte E-Mail-Adresse bei umich.edu
Jianping Fu, Ph.D.Mechanical & Biomedical Engineering, Cell & Developmental Biology, University of Michigan, Ann ArborBestätigte E-Mail-Adresse bei umich.edu
Michael A. Gorin, M.D.Icahn School of Medicine at Mount SinaiBestätigte E-Mail-Adresse bei mountsinai.org
Weiqiang ChenNew York UniversityBestätigte E-Mail-Adresse bei nyu.edu
Santiago SchnellCollege of Science, University of Notre DameBestätigte E-Mail-Adresse bei nd.edu
Wendy WoodwardProfessor, MD Anderson Cancer CenterBestätigte E-Mail-Adresse bei mdanderson.org
Kenneth PientaProfessor of Urology, Oncology, Pharmacology and Molecular Sciences, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
Paolo BoffettaProfessor, Stony Brook UniversityBestätigte E-Mail-Adresse bei stonybrookmedicine.edu
Mark L. WilsonProfessor Emeritus of Epidemiology, University of MichiganBestätigte E-Mail-Adresse bei umich.edu
Eduardo SontagNortheastern University ECE and BioEBestätigte E-Mail-Adresse bei northeastern.edu
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityBestätigte E-Mail-Adresse bei oncology.ox.ac.uk
Raymond H. W. LamAssociate Professor, Department of Biomedical Engineering, City University of Hong KongBestätigte E-Mail-Adresse bei cityu.edu.hk
Douglas ArenbergUniversity of MichiganBestätigte E-Mail-Adresse bei umich.edu
Chandan Kumar-SinhaUniversity of MichiganBestätigte E-Mail-Adresse bei umich.edu

Folgen

Sofia D. Merajver, MD, PhD

Professor of Internal Medicine and Epidemiology, University of Michigan

Bestätigte E-Mail-Adresse bei umich.edu - Startseite

Aggressive Breast cancer Metastases Cancer Metabolism Systems Biology Global Cancer Health


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ... Nature genetics 12 (3), 333-337, 1996	1137	1996
Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021	744	2021
BRCA1 regulates human mammary stem/progenitor cell fate S Liu, C Ginestier, E Charafe-Jauffret, H Foco, CG Kleer, SD Merajver, ... Proceedings of the National Academy of Sciences 105 (5), 1680-1685, 2008	590	2008
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ... Annals of oncology 22 (3), 515-523, 2011	556	2011
NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017 MB Daly, R Pilarski, M Berry, SS Buys, M Farmer, S Friedman, JE Garber, ... Journal of the National Comprehensive Cancer Network 15 (1), 9-20, 2017	521	2017
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Q Pan, CG Kleer, KL Van Golen, J Irani, KM Bottema, C Bias, ... Cancer research 62 (17), 4854-4859, 2002	512	2002
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours SD Merajver, TM Pham, RF Caduff, M Chen, EL Poy, KA Cooney, ... Nature genetics 9 (4), 439-443, 1995	508	1995
Assessment and counseling for women with a family history of breast cancer: a guide for clinicians KF Hoskins, JE Stopfer, KA Calzone, SD Merajver, TR Rebbeck, ... Jama 273 (7), 577-585, 1995	502	1995
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers SA Narod, MP Dubé, J Klijn, J Lubinski, HT Lynch, P Ghadirian, ... Journal of the National Cancer Institute 94 (23), 1773-1779, 2002	493	2002
BRCA2 germline mutations in male breast cancer cases and breast cancer families FJ Couch, LM Farid, ML DeShano, SV Tavtigian, K Calzone, L Campeau, ... Nature genetics 13 (1), 123-125, 1996	444	1996
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype KL van Golen, ZF Wu, XT Qiao, LW Bao, SD Merajver Cancer research 60 (20), 5832-5838, 2000	442	2000
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study GJ Brewer, RD Dick, DK Grover, V LeClaire, M Tseng, M Wicha, K Pienta, ... Clinical Cancer Research 6 (1), 1-10, 2000	440	2000
Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer LJ Pierce, AM Levin, TR Rebbeck, MA Ben-David, E Friedman, LJ Solin, ... Journal of Clinical Oncology 24 (16), 2437-2443, 2006	430	2006
NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines MB Daly, R Pilarski, MB Yurgelun, MP Berry, SS Buys, P Dickson, ... Journal of the National Comprehensive Cancer Network 18 (4), 380-391, 2020	377	2020
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor–negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23 B Fisher, S Anderson, E Tan-Chiu, N Wolmark, DL Wickerham, ER Fisher, ... Journal of clinical oncology 19 (4), 931-942, 2001	359	2001
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast … KL van Golen, S Davies, Z Fen Wu, YF Wang, CD Bucana, H Root, ... Clinical Cancer Research 5 (9), 2511-2519, 1999	344	1999
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ... Cancer research 66 (1), 41-45, 2006	331	2006
Targeting breast cancer stem cell state equilibrium through modulation of redox signaling M Luo, L Shang, MD Brooks, E Jiagge, Y Zhu, JM Buschhaus, S Conley, ... Cell metabolism 28 (1), 69-86. e6, 2018	322	2018
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability CG Kleer, KL van Golen, Y Zhang, ZF Wu, MA Rubin, SD Merajver The American journal of pathology 160 (2), 579-584, 2002	307	2002
Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants CG Kleer, KL van Golen, SD Merajver Breast Cancer Research 2, 1-7, 2000	297	2000

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren